Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Pelvic Floor Electrical Stimulation is a painless and effective procedure that treats urinary incontinence, frequency and urgency.Electrical Stimulation can be used to assist in strengthening very weak pelvic floor muscles by involuntarily (passively) contracting the pelvic floor muscles through the transmission of electrical impulses to the pelvic muscles. This stimulation heightens the patient’s perception and awareness of pelvic muscle activity and strengthens the muscles.
Due to the COVID-19 pandemic, the global Pelvic Floor Electrical Stimulation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pelvic Floor Electrical Stimulation Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pelvic Floor Electrical Stimulation Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Mobile accounting for % of the Pelvic Floor Electrical Stimulation Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Pelvic Floor Electrical Stimulation Devices include Utah Medical Products, Inc, Atlantic Therapeutics, The Prometheus Group, Zynex Medical, TensCare Ltd, Laborie, Inc, Verity Medical Ltd, Tic Medizintechnik GmbH and InControl Medical Limited and etc. In terms of revenue, the global 3 largest players have a % market share of Pelvic Floor Electrical Stimulation Devices in 2021.
This report focuses on Pelvic Floor Electrical Stimulation Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pelvic Floor Electrical Stimulation Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Pelvic Floor Electrical Stimulation Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Mobile
Fixed
Segment by Application
Hospitals
Clinics
Home Care
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Utah Medical Products, Inc
Atlantic Therapeutics
The Prometheus Group
Zynex Medical
TensCare Ltd
Laborie, Inc
Verity Medical Ltd
Tic Medizintechnik GmbH
InControl Medical Limited
Shenzhen XFT Medical Limited
Due to the COVID-19 pandemic, the global Pelvic Floor Electrical Stimulation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pelvic Floor Electrical Stimulation Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pelvic Floor Electrical Stimulation Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Mobile accounting for % of the Pelvic Floor Electrical Stimulation Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Pelvic Floor Electrical Stimulation Devices include Utah Medical Products, Inc, Atlantic Therapeutics, The Prometheus Group, Zynex Medical, TensCare Ltd, Laborie, Inc, Verity Medical Ltd, Tic Medizintechnik GmbH and InControl Medical Limited and etc. In terms of revenue, the global 3 largest players have a % market share of Pelvic Floor Electrical Stimulation Devices in 2021.
This report focuses on Pelvic Floor Electrical Stimulation Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pelvic Floor Electrical Stimulation Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Pelvic Floor Electrical Stimulation Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Mobile
Fixed
Segment by Application
Hospitals
Clinics
Home Care
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Utah Medical Products, Inc
Atlantic Therapeutics
The Prometheus Group
Zynex Medical
TensCare Ltd
Laborie, Inc
Verity Medical Ltd
Tic Medizintechnik GmbH
InControl Medical Limited
Shenzhen XFT Medical Limited
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
